Providers A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  4.5% 2.9% 1.2% 0.9% 0.8%  
Credit score (0-100)  48 58 80 88 90  
Credit rating  BBB BBB A A AA  
Credit limit (kDKK)  0.0 0.0 64.2 318.5 664.1  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  178 406 1,494 3,108 6,215  
EBITDA  178 228 999 2,541 5,194  
EBIT  138 180 670 2,217 3,685  
Pre-tax profit (PTP)  105.0 144.3 506.0 1,764.1 2,244.5  
Net earnings  78.3 104.6 482.2 1,275.2 1,952.1  
Pre-tax profit without non-rec. items  105 144 506 1,764 2,245  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  104 168 10,909 24,222 39,611  
Shareholders equity total  452 757 2,364 3,294 5,247  
Interest-bearing liabilities  519 581 975 2,691 7,126  
Balance sheet total (assets)  1,314 1,658 12,709 26,326 42,119  

Net Debt  519 581 975 2,691 7,109  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  178 406 1,494 3,108 6,215  
Gross profit growth  -15.2% 128.2% 267.8% 108.1% 99.9%  
Employees  0 0 0 3 3  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,314 1,658 12,709 26,326 42,119  
Balance sheet change%  41.7% 26.2% 666.6% 107.1% 60.0%  
Added value  178.0 228.0 998.6 2,544.9 5,193.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -44 16 10,412 12,989 13,880  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 3.0 4.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  77.5% 44.3% 44.9% 71.3% 59.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  11.9% 12.0% 9.4% 11.4% 10.8%  
ROI %  16.9% 15.5% 10.6% 13.8% 13.4%  
ROE %  19.0% 17.3% 30.9% 45.1% 45.7%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  34.4% 45.6% 18.6% 12.5% 12.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  291.6% 254.7% 97.7% 105.9% 136.9%  
Gearing %  114.8% 76.8% 41.2% 81.7% 135.8%  
Net interest  0 0 0 0 0  
Financing costs %  7.6% 6.3% 21.3% 25.2% 29.4%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.1 1.4 0.6 0.2 0.1  
Current Ratio  1.1 1.4 0.6 0.2 0.1  
Cash and cash equivalent  0.0 0.0 0.0 0.0 16.8  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  97.7 338.3 -1,006.0 -6,799.0 -13,328.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 848 1,731  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 847 1,731  
EBIT / employee  0 0 0 739 1,228  
Net earnings / employee  0 0 0 425 651